StopAfib.org has published the 2010 Most Popular Atrial Fibrillation News Stories and Videos List. Stroke prevention topped the list and included stories about warfarin (Coumadin) and alternatives such as dabigatran (Pradaxa) and rivaroxaban (Xarelto). Other popular topics included the new European atrial fibrillation guidelines, new antiarrhythmic medications, updates on catheter ablation and afib surgery, and …
Read MoreArchives
In late breaking clinical trials presented today at the American Heart Association Scientific Sessions, results of the ROCKET AF trial indicated that in an atrial fibrillation patient population that was at a very high risk of stroke, rivaroxaban (Xarelto) was as good as warfarin at preventing strokes. Learn more at: Rivaroxaban comparable to warfarin in …
Read MoreAn FDA panel today unanimously recommended that the FDA approve dabigatran (Pradaxa) for reducing the risk of afib strokes. FDA approval is expected quickly, making this the first alternative to warfarin approved in the United States, and also the first atrial fibrillation approval for dabigatran. It is approved in over 70 countries for venous thromboembolisms …
Read MoreNext Monday, September 20, 2010, StopAfib.org will be covering the FDA's hearing on dabigatran (Pradaxa), the new alternative to warfarin, and will be "live-tweeting" from the hearing. Get first reports as they happen by following @stopafib on Twitter. If you're already on Twitter, just follow us from the toolbar at the bottom of this page. …
Read MoreA new study exploring ethnic differences in stroke risk for people with atrial fibrillation (AF) showed that Mexican American stroke survivors with afib were more than twice as likely to have another stroke as comparable non-Hispanic white stroke survivors with afib. Researchers were surprised by the study’s finding that severity of recurrent stroke is also …
Read MoreWhether you're an atrial fibrillation patient or caregiver, or are just interested in learning more about afib, check out the new Get Started Learning About Atrial Fibrillation Guide at StopAfib.org. You'll find a wealth of information, including: what afib is and the problems it causes, including stroke and congestive heart failure information about an afib …
Read MoreStopAfib.org interviews Dr. Peter Kowey See the full transcript at: www.stopafib.org In this video interview at Boston Atrial Fibrillation Symposium 2010, Dr. Peter Kowey talked about a number of exciting new things in the atrial fibrillation world, including the Cabana clinical trials, the Safari catheter ablation registry, dronedarone as a …
Read MoreNot all atrial fibrillation patients are candidates for an ablation, either catheter ablation or surgical ablation, such as the maze or mini maze procedures. Thus their stroke risk remains high. We recently wrote about the FDA’s approval of the AtriClip device, which is implanted during open heart surgery and reduces stroke risk by occluding (closing …
Read MoreAF patients are generally at a higher risk for stroke and thus may have to take anticoagulant medications, such as Coumadin or warfarin, to manage their afib-related stroke risk. With the FDA's recent approval of AtriCure's AtriClip device that is implanted during open heart surgery, afib patients and their doctors may now have another way …
Read MoreIn this video from Boston Atrial Fibrillation Symposium 2010, Dr. Vivek Reddy discusses some of the new atrial fibrillation catheter ablation technologies and also talks about non-pharmacological approaches to stroke prevention in afib, such as the Watchman and Lariat suture. Dr. Reddy is the Director of Electrophysiology at Mount Sinai …
Read More